Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Kevin J Buchi

Affiliations

  • Chief Executive Officer at Biospecifics Technologies Corp (BSTC), 2019-10-25
  • Director at Dicerna Pharmaceuticals Inc (DRNA), 2019-06-22
  • Director at Amneal Pharmaceuticals Inc. (AMRX), 2019-05-08
  • Director at Impax Laboratories Llc (IPXL), 2018-05-08
  • Director at Alexza Pharmaceuticals Inc. (ALXA), 2016-06-21
  • Director at Stemline Therapeutics Inc (STML), 2015-06-25
  • Director at Epirus Biopharmaceuticals Inc. (EPRS), 2015-06-08
  • President & Ceo at Tetralogic Pharmaceuticals Corp (TLOG), 2015-03-30
  • Chief Executive Officer at Cephalon Inc (CEPH), 2011-10-17
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
TLOG $4.23 5,000 Officer, Director 330,714 2015-03-26 Filing
TLOG $5.04 5,000 Officer, Director 325,714 2015-01-07 Filing
TLOG $6.01 5,000 Officer, Director 320,714 2014-12-09 Filing
TLOG $4.99 10,000 Officer, Director 315,714 2014-12-02 Filing
TLOG $4.82 10,000 Officer, Director 305,714 2014-11-18 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CEPH $74.40 28,684 Officer 56,555 2006-02-17 Filing
CEPH $70.64 30,000 Officer 85,239 2010-03-05 Filing